Real-time enrollment status for this graft-versus-host disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:57 AM UTC
| NCT Number | NCT06343792 |
| Recruiting Status | Recruiting |
| Condition | Graft-versus-Host Disease |
| Phase | PHASE2 |
| Target Enrollment | 66 participants |
| Active Locations | 6 sites in the US |
| Sponsor | ReAlta Life Sciences, Inc. |
| Last Updated on CT.gov | November 24, 2025 (Nov 24, 2025) |
As of July 18, 2026: Clinical trial NCT06343792 is currently recruiting participants. This phase2 study for graft-versus-host disease is actively seeking new participants at 6 locations across the United States. The study is sponsored by ReAlta Life Sciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06343792 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06343792 was last updated Nov 24, 2025 (November 24, 2025). HelloStudys verifies this status automatically.